Cyclacel Pharma (CYCC) Tops Q1 EPS by 13c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/30/2026

1. NOW
2. GOOGL
3. MSFT
4. FTNT
5. EBAY
6. BIIB
7. CMG
8. TENB
9. KLAC
10. ETSY

Go back to Cyclacel Pharma (CYCC) Tops Q1 EPS by 13c

Cyclacel Pharmaceuticals Reports First Quarter 2020 Financial Results

May 12, 2020 4:05 PM EDT

- Conference Call Scheduled May 12, 2020 at 4:30 p.m. ET -

- Following Recent Financing Cash Runway to End of 2022 -

BERKELEY HEIGHTS, N.J., May 12, 2020 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; Cyclacel or the Company), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today reported its financial results for the first quarter 2020 and business highlights, including an update on its progress with fadraciclib, Cyclacel's novel CDK inhibitor. The Company's net loss applicable to common shareholders for the three months ended March 31, 2020 was $1.3... More